Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Aug 9;10(1):161.
doi: 10.1186/1477-7819-10-161.

The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis

Hakan Bozcuk  1 , Huseyin Abali, Senol Coskun; Lung Cancer Committee of Turkish Oncology Group
Collaborators, Affiliations
Meta-Analysis

The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis

Hakan Bozcuk et al. World J Surg Oncol. .

Abstract

Background: Although neoadjuvant chemotherapy (NCT) is widely used, it is not clear which subgroup of locally advanced non-small-cell lung cancer (NSCLC) patients should be treated with this approach, and if a particular benefit associated with NCT exists. In this study, we aimed to investigate the potential correlates of benefit from NCT in patients with NSCLC.

Methods: All randomized clinical trials (RCTs) utilizing a NCT arm (without radiotherapy) versus a control arm before surgery were included for metaregression analysis. All regression analyses were weighed for trial size. Separate analyses were conducted for trials recruiting patients with different stages of disease. Previously published measures of treatment efficacy were used for the purpose of this study, regardless of being published in full text or abstract form.

Results: A total of 14 RCTs, consisting of 3,615 patients, were selected. Histology, stage, various characteristics of the NCT protocol, and different trial features including trial quality score were not associated with the benefit of NCT. However, in trials of stage 3 disease only, there was a greater benefit in terms of reduction in mortality from NCT, if protocols with three chemotherapeutics were used (B = -0.18, t = -5.25, P = 0.006).

Conclusions: We think that patients with stage 3 NSCLC are served better with NCT before surgery if protocols with three chemotherapy agents or equally effective combinations are used. In addition, the effect of neoadjuvant chemotherapy is consistent with regard to disease and patient characteristics. This finding should be tested in future RCTs or individual patient data meta-analyses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of drugs in the neoadjuvant protocol and risk of death with respect to stage of non-small-cell lung cancer. This figure shows the activity of different numbers of chemotherapy drugs in the neoadjuvant chemotherapy protocol in different stages of disease.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. SEER: SEER Stat Fact Sheets. Lung and Bronchus. http://seer.cancer.gov/statfacts/html/lungb.html.
    1. NCCN. NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer, version 3 2011. http://www.nccn.com.
    1. Crinò L, Weder W, van Meerbeeck J, Felip E. on behalf of the ESMO Guidelines Working Group. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):103–115. - PubMed
    1. Burdett S, Stewart L, Rydzewska L. A systematic review and meta-analysis of the literature: chemotherapy and surgery verus surgery alone in non-small cell lung cancer. J Thorac Oncol. 2006;1:611–621. doi: 10.1097/01243894-200609000-00003. - DOI - PubMed
    1. Berghmans T, Paesmans M, Meert AP, Mascaux C, Lothaire P, Lafitte JJ, Sculier JP. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a metaanalysis of the literature. Lung Cancer. 2005;49:13–23. doi: 10.1016/j.lungcan.2005.01.002. - DOI - PubMed

Publication types

MeSH terms

Substances